They may technically include real GLP-1 medication, but we have no idea about whether its compounded and therefore poses safety risks. Dr South said GPs can push against this by directing their patients to trusted, quality information, including from the government and not-for-profit health organisations
Employers continue to need access to less expensive options to effectively treat obesity
They are designed to work on the same receptors as the natural hormone but more strongly or for longer, which is why they are typically taken weekly rather than daily
For those who maintained consistent GLP-1 use, medical cost growth was six to nine percentage points lower compared to non-users, and female GLP-1 users saw a 47% reduction in hospitalizations for major cardiovascular events
The ongoing pricing is above average
Evidence from previous studies show that weight loss can significantly reduce the risk of obesity-related complications and chronic diseases